Evan Lippman, EVP, Business Development: Teva Pharmaceutical Industries TEVA Planned sale · Filed 08/17

Trade details

Type: Planned sale notice
Stock: Teva Pharmaceutical Industries TEVA
Person: Evan LippmanEVP, Business Development
Planned sale date: 26/08/17
Filed: 26/08/17

$680.3K to be sold

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 07/18~09/16

Evan Lippman's recent trades

Evan LippmanEVP, Business Development
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$1.3M
35,912 sh
$1.3M
Filed 05/18
Traded 05/14
Evan LippmanEVP, Business Development
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$204.4K
5,746 sh
$204.4K
Filed 05/18
Traded 05/14
Evan LippmanEVP, Business Development
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$1.5M
41,658 sh
$1.5M
Filed 05/14
Traded 05/14